News

Engage with The Hackett Group's Q4 2024 Earnings Call Details

Engage with The Hackett Group's Q4 2024 Earnings Call Details

Join The Hackett Group for an Insightful Earnings Call

The Hackett Group, Inc. (NASDAQ: HCKT) is excited to announce its upcoming earnings conference call scheduled for February 18, 2025. This call follows the release of its fourth-quarter financial results for the period ending December 27, 2024, which will be made public after the market closes on that day.

Conference Call Information

During this informative conference call, senior management will discuss the company's fourth-quarter results in detail. The call will commence at 5:00 P.M. ET, providing an excellent opportunity for stakeholders and interested parties to gain insights from leading executives.

How to Participate

To participate in the conference call, dial (800) 593-0486; the passcode is Fourth Quarter. For international participants, the dial-in number is (517) 308-9371. It's recommended to join the call at least 5-10 minutes prior to the scheduled start time to ensure connectivity.

Rebroadcast and Webcast Information

If you are unable to join the call happening live, a rebroadcast will be accessible starting at 8:00 P.M. ET on the same day, continuing until 5:00 P.M. ET on March 4, 2025. To listen to the rebroadcast, use (866) 363-3999 for domestic calls, and (203) 369-0203 for international calls.

Online Participation Options

In addition to the audio call, The Hackett Group will offer an online webcast of the conference call. Interested participants are encouraged to visit their official website at approximately 10 minutes before the start of the call to access the live stream. The direct link will also provide access to an online replay after the live session concludes.

More Information on The Hackett Group

For further details about The Hackett Group and their offerings, please explore their website. There, you'll find resources and information that detail the company's events, services, and insights into industry trends.

Looking Ahead

The Hackett Group values the engagement of its stakeholders and is committed to transparency. We encourage everyone interested in the company’s performance and strategic direction to participate in this call. Your involvement is crucial as it helps foster communication between management and investors.

Frequently Asked Questions

What is the date and time of The Hackett Group's earnings call?

The earnings call is scheduled for February 18, 2025, at 5:00 P.M. ET.

How can I join the earnings call?

You can join by dialing (800) 593-0486 or (517) 308-9371 for international participants, using the passcode 'Fourth Quarter'.

Will there be a replay of the earnings call?

Yes, a rebroadcast will be available from 8:00 P.M. ET on February 18, 2025, until 5:00 P.M. ET on March 4, 2025.

Where can I find more information about The Hackett Group?

Additional information can be found on The Hackett Group's official website, which includes the latest news and resources.

What insights can I expect from the earnings call?

Expect to hear insights on financial performance and strategic direction from senior management during the call.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading